Explore more publications!

Middle East News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.

Press releases published on December 23, 2025

i-ESG Establishes Singapore Subsidiary to Accelerate Expansion Across Asia
Brand & AI Safety Summit Series Expands to Dubai, Channel Factory Joins Launch as Initial Title Partner
EAK Digital Wins Best Web3 Marketing & PR Agency of the Year at Entrepreneur Magazine Leadership Awards 2025
Panoro Minerals Ltd. Announces Closing of Final Tranche of Brokered LIFE Offering for Gross Proceeds of C$520,000
Brunswick Exploration Closes Upsized Non-Brokered Private Placement of $2.1 M
Brunswick Exploration clôture un placement privé sans courtier sursouscrit de 2,1 M$
Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Initial Drill Holes Returned Zn, Ag and Au Over Wide Widths on Globex Royalty Claims
Silynxcom Announces Over $1.3 Million in Purchase Orders from Israeli Defense Forces and Tactical Units in Recent Months
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of  Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones
Foresight Expands Road Safety Product Outreach in South Korea with a Strategic Cooperation Agreement
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
North American Niobium and Critical Minerals Corp. Advances Exploration with Radon Soil-Gas Survey Underway at Blanchette and Bardy Projects
Avicanna Announces Changes to its Board of Directors
Dynacor Group Announces January 2026 Dividend
Groupe Dynacor déclare son dividende pour janvier 2026
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions